These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8541954)

  • 21. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
    Hope RL; Weltman M; Dingley J; Fiatarone J; Hope AH; Craig PI; Grierson JM; Bilous M; Williams SJ; Farrell GC
    Med J Aust; 1995 Jan; 162(1):8-11. PubMed ID: 7845310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Precore stop codon mutant in chronic hepatitis B virus infection in children: its relation to hepatitis B e seroconversion and maternal hepatitis B surface antigen.
    Chang MH; Hsu HY; Ni YH; Tsai KS; Lee PI; Chen PJ; Hsu YL; Chen DS
    J Hepatol; 1998 Jun; 28(6):915-22. PubMed ID: 9672164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa.
    Gregorio GV; Jones H; Choudhuri K; Vegnente A; Bortolotti F; Mieli-Vergani G; Vergani D
    Hepatology; 1996 Sep; 24(3):520-3. PubMed ID: 8781317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of chronic viral hepatitis B in children with moderate doses of alpha interferon].
    Cullu F; Tümay GT; Kutlu T; Erkan T; Ozbay G; Badur S
    Gastroenterol Clin Biol; 1995 Jan; 19(1):53-7. PubMed ID: 7720991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GB virus C (GBV-C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: effect of interferon alfa therapy.
    Pawlotsky JM; Roudot-Thoraval F; Muerhoff AS; Pellerin M; Germanidis G; Desai SM; Bastie A; Darthuy F; Rémiré J; Zafrani ES; Soussy CJ; Mushahwar IK; Dhumeaux D
    J Med Virol; 1998 Jan; 54(1):26-37. PubMed ID: 9443106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-induced chronic active hepatitis?
    Silva MO; Reddy KR; Jeffers LJ; Hill M; Schiff ER
    Gastroenterology; 1991 Sep; 101(3):840-2. PubMed ID: 1860646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term persistence of hepatitis B virus DNA in the serum of children with chronic hepatitis B after hepatitis B e antigen to antibody seroconversion.
    Bortolotti F; Wirth S; Crivellaro C; Alberti A; Martine U; de Moliner L
    J Pediatr Gastroenterol Nutr; 1996 Apr; 22(3):270-4. PubMed ID: 8708880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C.
    García-Buey L; García-Monzón C; Rodriguez S; Borque MJ; García-Sánchez A; Iglesias R; DeCastro M; Mateos FG; Vicario JL; Balas A
    Gastroenterology; 1995 Jun; 108(6):1770-7. PubMed ID: 7768382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No evidence of autoimmunity in 6-year-old children immunized at birth with recombinant hepatitis B vaccine.
    Belloni C; Avanzini MA; De Silvestri A; Martinetti M; Pasi A; Coslovich E; Autelli M; Masanti ML; Cuccia M; Tinelli C; Rondini G; Lorini R
    Pediatrics; 2002 Jul; 110(1 Pt 1):e4. PubMed ID: 12093985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of hepatitis B virus precore mutants in patients with chronic hepatitis B responding to interferon-alpha.
    Xu J; Brown D; Harrison T; Lin Y; Dusheiko G
    Hepatology; 1992 Jun; 15(6):1002-6. PubMed ID: 1592338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a 10-month follow-up study.
    Coppens JP; Cornu C; Lens E; Lamy M; Geubel A
    Liver; 1989 Oct; 9(5):307-13. PubMed ID: 2685491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zidovudine plus interferon alfa-2b treatment in patients with HIV and chronic active viral hepatitis.
    Visco G; Alba L; Grisetti S; Guarascio P; Narciso P; Sette P; Struglia C; Tossini G; Tozzi V
    Gut; 1993; 34(2 Suppl):S107-8. PubMed ID: 8314472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon alfa-2b in renal transplant recipients with viral chronic hepatitis: a pilot study.
    Monteon FJ; Contreras AM; Espinoza L; Vazquez G; Aguilar S; Cueva L
    Transplant Proc; 1996 Dec; 28(6):3306-8. PubMed ID: 8962284
    [No Abstract]   [Full Text] [Related]  

  • 36. Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B.
    Hadziyannis S; Bramou T; Makris A; Moussoulis G; Zignego L; Papaioannou C
    J Hepatol; 1990; 11 Suppl 1():S133-6. PubMed ID: 2079571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B.
    Mellerup MT; Krogsgaard K; Mathurin P; Gluud C; Poynard T
    Cochrane Database Syst Rev; 2002; (2):CD000345. PubMed ID: 12076393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon alfa-2b therapy in children with chronic hepatitis B.
    Sokal EM; Wirth S; Goyens P; Depreterre A; Cornu C
    Gut; 1993; 34(2 Suppl):S87-90. PubMed ID: 8314496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is there a role for interferon in acute viral hepatitis?
    Esteban R
    Gut; 1993; 34(2 Suppl):S77-80. PubMed ID: 8314495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation between autoimmune hepatitis and hepatitis C virus related liver disease.
    Heintges T; Niederau C
    Z Gastroenterol; 1993 May; 31(5):285-8. PubMed ID: 7686702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.